About this Research Topic
This issue wishes to cover what is clinically unique about onconephrology, including the pathophysiology and treatment of various cancer-associated kidney complications with a focus on acute kidney injury, chronic kidney disease, drug-induced nephrotoxicity of emerging therapies, kidney disease in stem cell transplantation, and electrolyte disorders.
This Research Topic will focus on different aspects of onconephrology and will provide insights for future research and clinical practices. Some possible themes are AKI in cancer patients, chemotherapy nephrotoxicity, CKD and chemotherapy, myeloma kidney and monoclonal gammopathy of renal significance, check point inhibitors nephrotoxicity, rechallenge and kidney transplantation, targeted therapies and kidney, CAR-T cell and cytokine release syndrome, and bone marrow transplantation associated AKI. We invite you to submit the most recent trends, developments, clinical practice, and challenges in these themes as original research papers, reviews, meta-analyses, systematic reviews, opinions, or perspectives papers.
Keywords: Onconephrology, acute kidney injury, cancer, CAR-T cell, kidney transplantation, chemotherapy nephrotoxicity, icp nephrotoxicity, icp rechallenge, targeted therapies nephrotoxicity, chronic kidney disease, electrolyte disorders, myeloma kidney, monoclonal gammopathy of renal significance, bone marrow associated aki
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.